Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute.
Navaneeth NarayananAmy J MathersEric WenzlerNicholas M MooreChristian G GiskeRodrigo E MendesPaul H EdelsteinPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)